Navigation Links
Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - Pfizer announced today that Lipitor (atorvastatin calcium) Tablets 80 mg reduced the risk of stroke, coronary heart disease events and major coronary events in type 2 diabetes patients who had no known coronary heart disease but who had experienced a recent stroke or mini-stroke, compared with placebo. The results are from a new analysis of the landmark Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, and were presented at the 67th Annual Scientific Sessions of the American Diabetes Association.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, the risk for stroke is two to four times higher among people with diabetes, and heart disease and stroke account for nearly two-thirds of deaths in people with diabetes.

"People with type 2 diabetes who have had a stroke are at a much higher risk of having a second stroke, a coronary heart disease event or revascularization procedure than people without type 2 diabetes," said Dr. Michael Welch, lead SPARCL investigator, neurologist and president of Rosalind Franklin University of Medicine & Science. "In this analysis of patients with type 2 diabetes with no known coronary heart disease, we found Lipitor to be effective in reducing these risks."

In this pre-specified analysis (n=794), Lipitor reduced the risk of stroke by 30 percent, and coronary heart disease events and major coronary events by 51 percent, compared with placebo. Coronary heart disease events include cardiac death, heart attack, resuscitated cardiac arrest, unstable chest pain, revascularization, or chest pain requiring emergency hospitalization. Major coronary events include cardiac death, heart attack, or resuscitated cardiac arrest.

An additional analysis evaluated 781 patients in the SPARCL trial who were classified as having metabolic syndrome and who had a recent stroke o
'"/>




Page: 1 2 3

Related medicine technology :

1. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
2. Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients
3. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
4. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
5. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
6. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
9. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
10. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
11. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
Post Your Comments:
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... 26, 2014 Novira Therapeutics, Inc., a privately ... of chronic hepatitis B virus (HBV) infection, today announced ... appointed the Chair of its Scientific Advisory Board (SAB). ... Senior Advisor to the Company.  "We ... Chair," said Christian Schade , Chief Executive Officer ...
(Date:8/26/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.22 per share will ... of record as of the close of business on September ... of the Board of Directors and may be adjusted as ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... Calif., Dec. 6 DURECT Corporation,(Nasdaq: ... Phase III trial for Remoxy,had successfully met ... by the U.S. Food and Drug Administration ... an investigational drug based on,DURECT,s patented ORADUR(TM) ...
... Colo., Dec. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... Collins will participate on the New and Powerful Anti-infectives,panel ... panel,discussion will take place at 11:00 am ET on ... New York City., A live audio webcast of ...
Cached Medicine Technology:Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 2Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 4
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... governance, and compliance software solutions for next-generation social ... Inc. magazine’s Inc. 500|5000, an exclusive ranking of ... consecutive year. AvePoint joins brands such as Alex ... 2014 edition. , This underscores continued growth ...
(Date:8/27/2014)... BambooIndustry.com is one of the most loved online bamboo product ... sale now. Recently, it has announced its new selection of ... BambooIndustry.com strives to offer one-stop shopping solutions for people who ... Now, it is providing big discounts for all the brand ... enjoy a discounted price (up to 30% off) before the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... on August 1, that Organic Raw Carob Powder sold ... recalled due to possible contamination with Salmonella. ... with weakened immune systems. In healthy people it can ...
(Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 The ... improve quality of life and may eliminate the need ... controversy. During a recent AllMed webinar, Dr. Zanhua Yi, ... issues related to determining medical necessity of erythropoiesis-stimulating agents ... disease (CKD). , The U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3
... The Songs of Love ... uplifting, personalized songs for children and teens struggling with a life-threatening ... professionally produced with lyrics containing the child,s name and references to ... Songs are written and performed in the musical style that the ...
... improved hearing and alleviated other symptoms in patients with ... appear in the July 23 New England Journal ... researchers from Massachusetts General Hospital (MGH) report that bevacizumab ... of NF2 patients, the first reported successful NF2 treatment ...
... The world-wide explosion of overweight people has been called ... recognized. Could it really be an epidemic involving an ... increasing prevalence of overweight conditions in our society, investigators ... as a potential direct contributor to obesity. ...
... WASHINGTON, July 8 The results of a study published ... Journal (BMJ) support the findings of a white paper released ... (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs ... "In patients without established cardiovascular disease but with cardiovascular risk ...
... , TROIS-RIVIERES, Quebec, July 8 The Narconon drug rehab ... involved with drug related charges due to their addiction. ... a drug addiction, and just one day gets caught by ... a representative of Narconon Trois-Rivieres. "This is an all ...
... July 8 On the heels of a new campaign launched ... to unsightly "canckles," Dr. Marc Mittleman, founder and director of ... clubs and their members to focus on a real health issue ... in warm, moist environments like locker rooms, communal showers, pool and ...
Cached Medicine News:Health News:Donate Your Car to the Songs of Love Car Donation Program 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 3Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:Drug Crimes in Canada Cause Continuing Problems for Small Communities 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 3
30 cm - 11 3/4, packages 5 pcs....
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Medicine Products: